SCHEMBL18326957

SCHEMBL18326957

c1ccc(N(c2cccc(-c3cccc4ccccc34)c2)c2ccc3c(c2)oc2ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.39
▸ ACMSD Q8TDX5 1/20 0.39
▸ AHR P35869 2/20 0.38
▸ DUSP3 P51452 1/20 0.38
▸ MAPT P10636 5/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ALOX5 P09917 1/20 0.36
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23224576 0.97 MCL1 (0.40) MCL1ACMSDAHRDUSP3MAPT
SCHEMBL18326990 0.97 MCL1 (0.38) MCL1ACMSDAHRDUSP3MAPT
SCHEMBL23224506 0.97 MCL1 (0.40) MCL1ACMSDAHRDUSP3MAPT
SCHEMBL24919120 0.97 AHR (0.40) MCL1ACMSDAHRDUSP3MAPT
SCHEMBL21124043 0.96 MCL1 (0.40) MCL1ACMSDAHRDUSP3MAPT
SCHEMBL23224572 0.96 MCL1 (0.39) MCL1ACMSDAHRDUSP3MAPT
SCHEMBL23239560 0.95 MCL1 (0.39) MCL1ACMSDAHRDUSP3MAPT
SCHEMBL23239596 0.95 MCL1 (0.39) MCL1ACMSDAHRDUSP3MAPT
SCHEMBL23224523 0.95 MCL1 (0.39) MCL1ACMSDAHRDUSP3MAPT
SCHEMBL23237295 0.95 MCL1 (0.39) MCL1ACMSDAHRDUSP3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed
US-20200290986-A1 MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2020-09-17 — — US disclosed
US-10693079-B2 Mono amine derivatives and organic electroluminescent device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-23 — — US disclosed
US-20160372677-A1 MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-12-22 — — US disclosed
US-20160372677-A1 MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200290986-A1 MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME MAOA, MAOB, TAAR1 MCL1 2675/4885ACMSD 932/4885AHR 108/4885
US-10693079-B2 Mono amine derivatives and organic electroluminescent device including the same CHRM1, NAP1L1, NAT1 MCL1 2295/4885ACMSD 1184/4885AHR 138/4885
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 MCL1 1725/4885ACMSD 1115/4885AHR 3895/4885
US-20160372677-A1 MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME CHRM1, NAP1L1, NAT1 MCL1 2295/4885ACMSD 1184/4885AHR 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback